Eastman Chemical (EMN) Tops Q4 EPS by 11c, FY15 Guidance Misses
Get Alerts EMN Hot Sheet
Revenue Growth %: -5.4%
Financial Fact:
Cash dividends declared: -69M
Today's EPS Names:
BFRI, HCTI, IMPM, More
Join SI Premium – FREE
Eastman Chemical (NYSE: EMN) reported Q4 EPS of $1.64, $0.11 better than the analyst estimate of $1.53. Revenue for the quarter came in at $2.35 million versus the consensus estimate of $2.34 million.
Commenting on the outlook for full year 2015, Costa said: “We enter 2015 well positioned to benefit from our strong portfolio of specialty businesses, including the accretive acquisitions we completed in 2014. We are confident that we will continue to deliver long-term value from our leadership positions in key markets, the diversity of end-markets and geographies we serve, and market adoption of our specialty products. In the short-term, we also face challenges including continued global economic uncertainty, volatile oil prices, and the recent strengthening of the U.S. dollar. Under current business conditions, we expect 2015 earnings per share to be similar to 2014 earnings per share.” Non-core and non-recurring items are excluded from the earnings per share projection.
(Street sees FY15 EPS of $7.45)
For earnings history and earnings-related data on Eastman Chemical (EMN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FreightCar America (RAIL) Misses Q4 EPS by 6c, provides guidance
- Zepp Health Corporation (ZEPP) Misses Q4 EPS by 134c
- Alpine Immune Sciences (ALPN) Reports FY Loss of $0.64
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!